The future of EPAC-targeted therapies: agonism versus antagonism

Trends in Pharmacological Sciences
Euan ParnellStephen J Yarwood

Abstract

Pharmaceutical manipulation of cAMP levels exerts beneficial effects through the regulation of the exchange protein activated by cAMP (EPAC) and protein kinase A (PKA) signalling routes. Recent attention has turned to the specific regulation of EPAC isoforms (EPAC1 and EPAC2) as a more targeted approach to cAMP-based therapies. For example, EPAC2-selective agonists could promote insulin secretion from pancreatic β cells, whereas EPAC1-selective agonists may be useful in the treatment of vascular inflammation. By contrast, EPAC1 and EPAC2 antagonists could both be useful in the treatment of heart failure. Here we discuss whether the best way forward is to design EPAC-selective agonists or antagonists and the current strategies being used to develop isoform-selective, small-molecule regulators of EPAC1 and EPAC2 activity.

References

Dec 18, 1998·Science·H KawasakiA M Graybiel
Apr 25, 2000·The Journal of Biological Chemistry·J de RooijJ L Bos
Apr 18, 2002·British Journal of Pharmacology·María-Jesús SanzEsteban J Morcillo
Jun 8, 2002·Current Pharmaceutical Design·Catherine Burnouf, Marie-Pierre Pruniaux
Mar 11, 2003·The Journal of Biological Chemistry·Matthew C Trudeau, William N Zagotta
May 30, 2003·The Biochemical Journal·Peter C HeinrichFred Schaper
Jul 31, 2003·The Journal of Biological Chemistry·Holger RehmannJohannes L Bos
Feb 22, 2005·Pediatric Nephrology : Journal of the International Pediatric Nephrology Association·Jane C Tan, Ralph Rabkin
Jul 12, 2005·Nature Medicine·Daewoong JoJacek Hawiger
Aug 24, 2005·FEBS Letters·Matthijs R H KooistraJohannes L Bos
Feb 6, 2007·Current Opinion in Pharmacology·Martina SchmidtPaschal A Oude Weernink
May 26, 2007·Nature Reviews. Immunology·Akihiko YoshimuraMasato Kubo
Oct 24, 2007·The Journal of Cell Biology·Angela GladingMark H Ginsberg
Nov 28, 2007·Proceedings of the National Academy of Sciences of the United States of America·Tadao ShibasakiSusumu Seino
Dec 8, 2007·Journal of Cellular Physiology·Anna A BirukovaKonstantin G Birukov
Apr 1, 2008·Nature Methods·Heiko PoppeElke Butt
May 20, 2008·Cardiovascular Research·Robert KleemannTeake Kooistra
Jun 27, 2008·Pancreas·Richard LorenzChristoph K Weber
Jul 18, 2008·Chembiochem : a European Journal of Chemical Biology·Marjolein J VliemHolger Rehmann
Mar 25, 2009·Pharmacological Reports : PR·Mélanie MétrichFrank Lezoualc'h
May 1, 2009·The Journal of Biological Chemistry·Rahul DasGiuseppe Melacini
Aug 1, 2009·Science·Chang-Liang ZhangSusumu Seino
Oct 27, 2009·Pflügers Archiv : European journal of physiology·Mélanie MétrichFrank Lezoualc'h
Aug 1, 2008·Current Cardiology Reviews·Tieying HouAllan R Brasier
Dec 17, 2009·American Journal of Physiology. Endocrinology and Metabolism·Oleg G ChepurnyGeorge G Holz
Jun 16, 2010·Molecular and Cellular Biology·Chang LiuPhilip J S Stork
Oct 26, 2010·Journal of Molecular and Cellular Cardiology·Richard C HewerMark Bond
Dec 8, 2010·Assay and Drug Development Technologies·Tamara TsalkovaXiaodong Cheng

❮ Previous
Next ❯

Citations

Feb 9, 2016·Canadian Journal of Physiology and Pharmacology·Yan YangJun Li
Mar 2, 2016·Proceedings of the National Academy of Sciences of the United States of America·Pooja SinghmarAnnemieke Kavelaars
Sep 24, 2015·Gene·Kenji SugawaraSusumu Seino
Jul 6, 2016·Frontiers in Endocrinology·Aurélia E LewisMarit Bakke
Aug 24, 2016·Cellular and Molecular Life Sciences : CMLS·Takayuki FujitaYoshihiro Ishikawa
Sep 22, 2016·Antioxidants & Redox Signaling·Zhaokang YangDerek S Steele
Mar 16, 2016·PLoS Genetics·Roberta PaloriniFerdinando Chiaradonna
Mar 25, 2017·International Journal of Molecular Sciences·Eric P KnottDamien D Pearse
Mar 15, 2018·Physiological Reviews·William G Robichaux, Xiaodong Cheng
Jan 26, 2018·Journal of Cardiovascular Development and Disease·Graeme BarkerStephen J Yarwood
Jun 9, 2018·Thyroid : Official Journal of the American Thyroid Association·Danielle J HukLawrence S Kirschner
Sep 20, 2018·Diabetes, Obesity & Metabolism·Jing W HughesDavid W Piston
Mar 5, 2016·Circulation Research·Frank Lezoualc'hCaroline Conte
Dec 7, 2018·American Journal of Physiology. Gastrointestinal and Liver Physiology·Irene Ramos-AlvarezR T Jensen
May 19, 2019·Naunyn-Schmiedeberg's Archives of Pharmacology·Klaus AktoriesThomas Wieland
Jun 19, 2019·Proceedings of the National Academy of Sciences of the United States of America·Faisa OmarDavid J P Henderson
Jun 28, 2019·Frontiers in Immunology·Selena ViganoGeorge Coukos
Feb 11, 2019·Molecular and Cellular Biochemistry·Diana J Goode, Derek C Molliver
Aug 8, 2019·Nature Reviews. Drug Discovery·George S BaillieMichy P Kelly
Aug 31, 2017·Molecular Cancer Research : MCR·Carlos I RodríguezVijayasaradhi Setaluri
May 13, 2020·Oncology Reviews·Seidu A Richard
Jun 10, 2021·Acta Pharmacologica Sinica·Wen-Xia YangLi Xiao
Oct 17, 2020·Neurotherapeutics : the Journal of the American Society for Experimental NeuroTherapeutics·Cosmin I Ciotu, Michael J M Fischer

❮ Previous
Next ❯

Methods Mentioned

BETA
nucleotide exchange
GTPase
fluorescence resonance
FRET
coronary artery bypass

Related Concepts

Related Feeds

Cardiovascular Disease Pathophysiology

Cardiovascular disease involves several different processes that contribute to the pathological mechanism, including hyperglycemia, inflammation, atherosclerosis, hypertension and more. Vasculature stability plays a critical role in the development of the disease. Discover the latest research on cardiovascular disease pathophysiology here.

Atrial Fibrillation

Atrial fibrillation is a common arrhythmia that is associated with substantial morbidity and mortality, particularly due to stroke and thromboembolism. Here is the latest research.

Arterial-Venous in Development & Disease

Arterial-venous development may play a crucial role in cardiovascular diseases. Here is the latest research.

CV Disorders & Type 2 Diabetes

This feed focuses on the association of cardiovascular diseases in patients with type 2 diabetes.

Cardiovascular Inflammation

Inflammation plays a significant role in the development of cardiovascular diseases, an understanding of these endogenous processes is critical for evaluating the risks and potential treatment strategies. Discover the latest research on cardiovascular inflammation here.

Arrhythmia

Arrhythmias are abnormalities in heart rhythms, which can be either too fast or too slow. They can result from abnormalities of the initiation of an impulse or impulse conduction or a combination of both. Here is the latest research on arrhythmias.

Anti-inflammatory Treatments

A drug or substance that reduces inflammation (redness, swelling, and pain) in the body. Anti-inflammatory agents block certain substances in the body that cause inflammation and swelling. Discover the latest research on anti-inflammatory treatments here

Atherosclerosis Disease Progression

Atherosclerosis is the buildup of plaque on artery walls, causing stenosis which can eventually lead to clinically apparent cardiovascular disease. Find the latest research on atherosclerosis disease progression here.